S

Sosei Group Corp
TSE:4565

Watchlist Manager
Sosei Group Corp
TSE:4565
Watchlist
Price: 1 033 JPY 1.08% Market Closed
Market Cap: 92.9B JPY
Have any thoughts about
Sosei Group Corp?
Write Note

Sosei Group Corp
Depreciation & Amortization

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sosei Group Corp
Depreciation & Amortization Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Depreciation & Amortization CAGR 3Y CAGR 5Y CAGR 10Y
S
Sosei Group Corp
TSE:4565
Depreciation & Amortization
ÂĄ4B
CAGR 3-Years
45%
CAGR 5-Years
23%
CAGR 10-Years
69%
Takeda Pharmaceutical Co Ltd
TSE:4502
Depreciation & Amortization
ÂĄ758.5B
CAGR 3-Years
10%
CAGR 5-Years
7%
CAGR 10-Years
13%
Daiichi Sankyo Co Ltd
TSE:4568
Depreciation & Amortization
ÂĄ64.4B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
6%
Otsuka Holdings Co Ltd
TSE:4578
Depreciation & Amortization
ÂĄ107.9B
CAGR 3-Years
9%
CAGR 5-Years
9%
CAGR 10-Years
7%
Chugai Pharmaceutical Co Ltd
TSE:4519
Depreciation & Amortization
ÂĄ31.7B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Astellas Pharma Inc
TSE:4503
Depreciation & Amortization
ÂĄ195.9B
CAGR 3-Years
38%
CAGR 5-Years
26%
CAGR 10-Years
12%
No Stocks Found

Sosei Group Corp
Glance View

Market Cap
92.9B JPY
Industry
Pharmaceuticals

Sosei Group Corp. engages in the discovery, design, and development of medicines targeting G protein-coupled receptors (GPCRs). The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 198 full-time employees. The company went IPO on 2004-07-29. The pharmaceutical business is engaged in the research, development and sales of medicines, the management of regenerative medical funds, the investment in bio venture companies related to regenerative medicine, the overseas development by licensing, the promotion of commercialization, the structural analysis of GPCR, the initial lead compound creation, the candidate search by proprietary StaR technology, as well as structural base of new drugs using GPCR related basic technology drug discovery, screening, promotion of antibody drug research and development.

Intrinsic Value
1 330.98 JPY
Undervaluation 22%
Intrinsic Value
Price
S

See Also

What is Sosei Group Corp's Depreciation & Amortization?
Depreciation & Amortization
4B JPY

Based on the financial report for Sep 30, 2024, Sosei Group Corp's Depreciation & Amortization amounts to 4B JPY.

What is Sosei Group Corp's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
69%

Over the last year, the Depreciation & Amortization growth was 115%. The average annual Depreciation & Amortization growth rates for Sosei Group Corp have been 45% over the past three years , 23% over the past five years , and 69% over the past ten years .

Back to Top